Indeed, it was reported that resistance to treatment was coherent with MCT4 overexpression, suggesting that MCT4, although having a lower affinity for lactate [48], could be compensating and maintaining lactate exchanges in Burkitt’s lymphoma since it was not inhibited by AZD3965 [33]. This evidence concerns the gene SLC16A3 and Burkitt lymphoma.